Ben Davidson research group

B. Davidson

The research group is focusing on the characterization of ovarian carcinoma cells in effusions, with comparative models of breast carcinoma and malignant mesothelioma.

We focus on:

Optimizing cancer diagnosis in effusions
Mapping events mediating invasion and metastasis
Studying genetic events and their clinical significance
Identifying pro-survival molecules

[449 visits]

Go back

Print this page

E-mail this page

News & events

News article in Nature on Norwegian plans for using tumour-sequencing techniques to help guide cancer care
Feb 3, 2012

Institute seminars spring season 2012
Jan 23, 2012

Aiming at national support for targeted cancer therapy research
Jan 18, 2012

Institute Seminar – January 18th
Christos Samakovlis: The molecular basis of airway maturation in Drosophila
Jan 17, 2012

Bjarne Bogen appointed "Scientist of the Month" by "Helse Sør-Øst" for January 2012
Jan 16, 2012

More news

Latest publications

Ben Davidson

Hetland TE, Kærn J, Skrede M, Sandstad B, Tropé C, Davidson B, Flørenes VA
Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index
Cancer Chemother Pharmacol (in press)
PubMed 22302409

Brenne K, Nymoen DA, Reich R, Davidson B (2012)
PRAME (Preferentially Expressed Antigen of Melanoma) Is a Novel Marker for Differentiating Serous Carcinoma From Malignant Mesothelioma
Am J Clin Pathol, 137 (2), 240-7
PubMed 22261449

Brusegard K, Stavnes HT, Nymoen DA, Flatmark K, Trope CG, Davidson B
Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma
Virchows Arch (in press)
PubMed 22249560

More publications